Moderna spikes 19% amid a flood of encouraging vaccine news, surpassing Merck in market value
Drew Angerer/Getty Images
- Moderna soared as much as 19% on Monday amid a flood of news suggesting that demand for its COVID-19 vaccine will continue to be strong.
- Monday’s move catapulted Moderna ahead of Merck in market value, giving the mRNA developer…
